<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is increasing in incidence and has a high mortality unless detected early </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is the only known risk factor for this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>; however, whether endoscopic surveillance reduces morbidity and mortality is controversial </plain></SENT>
<SENT sid="2" pm="."><plain>Endoscopic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance programes for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with a diagnosis of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> attending Havering Hospitals NHS Trust between 1992 and 1998 were included </plain></SENT>
<SENT sid="4" pm="."><plain>A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998) </plain></SENT>
<SENT sid="5" pm="."><plain>Over the same time periods Barrett's associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998) </plain></SENT>
<SENT sid="6" pm="."><plain>From 1992 to 1997, one case of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was detected (N = 96, 1%) </plain></SENT>
<SENT sid="7" pm="."><plain>From 1997 to 1998, two <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and three high-grade <z:mpath ids='MPATH_589'>dysplasias</z:mpath> were detected during rigorous surveillance (N = 108, 4.6%) </plain></SENT>
<SENT sid="8" pm="."><plain>Three of these patients have had curative esophagectomies (one high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and two T1,N0,M0 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>) </plain></SENT>
<SENT sid="9" pm="."><plain>In 1992-1997, 10 patients were found to have <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in previously undiagnosed <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (N = 262, 3.8%) </plain></SENT>
<SENT sid="10" pm="."><plain>Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0) </plain></SENT>
<SENT sid="11" pm="."><plain>In 1997-1998, nine patients were found to have de novo <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (N = 88, 10.2%) and three had curative resections (T1,N0,M0) </plain></SENT>
<SENT sid="12" pm="."><plain>Two of the patients with T1 lesions had no endoscopic evidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> but were detected as a result of the multiple biopsy protocol </plain></SENT>
<SENT sid="13" pm="."><plain>In conclusion, a rigorous biopsy protocol increases the detection of early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>